OncoArendi weźmie udział w następujących konferencjach i wydarzeniach

ERS - 9-13 September 2017 Milan

OncoArendi will present a poster on The Therapeutic Efficacy of OAT-889 (DualAMCase/CHIT1 Inhibitor) in Comparison to Montelukast in HDM-induced Model of Chronic Airway Inflammation in Mice, on Wednesday 13th, 10th at 8:30 AM. (link: Poster OAT-889 ERS 2017)

ESMO - 8-12 September 2017 Madrid

OncoArendi will present a poster on the development of a novel arginase 1 and 2 inhibitor for cancer immunotherapy, on Sunday, 10th at 1PM. (link: OAT-1746 ESMO 2017)

BIO USA - San Diego 19-22 June 2017

The company presentation will take place on Tuesday, 20th of June, at 3:15 PM in Theatre 4.

ATS - Washington 19-24 May 2017

A poster will be presented on Monday, 22nd of May from 9AM (link: poster OAT-889 ATS 2017)